MELINDA BRASWELL: Open Payments
NPI 1568455863 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 11 payments from 10 companies in 2025. Trend: 2023 $1,364 · 2024 $658 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $111 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $23 |
| Noven Therapeutics, LLC | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: Auvelity, COBENFY, TRINTELLIX, REXULTI, Xelstrym, FANAPT, ARISTADA, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
